19 results
8-K
EX-1.1
OPTN
OptiNose Inc
23 Nov 22
Optinose Announces Proposed Public Offering of Common Stock and Warrants
4:09pm
laws or regulatory bodies, including, but not limited to, all laws applicable to ownership, testing, development, manufacture, packaging, processing
8-K
EX-10.1
OPTN
OptiNose Inc
21 Nov 22
Entry into a Material Definitive Agreement
6:16am
, processing, packaging, promotion, sale, distribution, or holding thereof, or any comparable correspondence from any foreign counterpart of the FDA … post-marketing safety reports for combination products), manufacture, production, packaging, labeling, use, commercialization, marketing, promotion
8-K
EX-1.1
OPTN
OptiNose Inc
18 Nov 21
Optinose Announces Proposed Public Offering of Common Stock
12:20pm
, testing, development, manufacture, packaging, processing, use, distribution, marketing, advertising, labeling, promotion, sale, offer for sale, storage
8-K
EX-1.1
frf5e8s05d2xm u6xwno
18 Aug 20
Optinose Announces Pricing of Public Offering of Common Stock
12:00am
8-K
EX-1.1
gef 0u9jc8
21 Nov 19
Optinose Announces Proposed Public Offering of Common Stock
5:11pm
8-K
EX-10.1
otjolm5x9
12 Sep 19
Announces $150 Million Debt Financing from Pharmakon
4:04pm
10-K
EX-10.19
dfc35szq
13 Mar 18
Annual report
12:00am
10-K
88xa h8hm5n77z
13 Mar 18
Annual report
12:00am
424B4
kdezhg9xm0
13 Oct 17
Prospectus supplement with pricing info
12:00am
- Prev
- 1
- Next